Lipid management update: Where does inclisiran fit in? Oct. 01, 2022 Overview Show transcript Overview Mayo Clinic cardiologists Christopher V. DeSimone, M.D., Ph.D., and Stephen Kopecky, M.D. review the drug inclisiran for cholesterol management, who may be a candidate, adherence and efficacy. This video was first published on Medscape Cardiology | theheart.org. Learn more about referring patients to Mayo Clinic. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentVideoCardiovascular Medicine Webinar — Newer approaches to lipid therapy beyond statins: Options, pitfalls and guidance on useArticlePCSK9 inhibition: A game changer in cholesterol management VID-20540747 Medical Professionals Lipid management update: Where does inclisiran fit in?